Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Diagnosis × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Childhood Brain Neoplasm 1 Breast Neoplasms 1

Interventions

Trastuzumab 495 Paclitaxel 470 Cyclophosphamide 461 Docetaxel 410 Capecitabine 341 Letrozole 291 Fulvestrant 255 Doxorubicin 239 Carboplatin 226 Tamoxifen 213 Anastrozole 177 Radiotherapy 174 exemestane 171 Epirubicin 170 Bevacizumab 161 Lapatinib 142 Vinorelbine 139 Gemcitabine 137 pertuzumab 135 pembrolizumab 135 palbociclib 120 Exercise 109 Fluorouracil 101 Magnetic Resonance Spectroscopy 99 Albumin-Bound Paclitaxel 99 eribulin 94 130-nm albumin-bound paclitaxel 87 Everolimus 84 Cisplatin 79 Taxes 76

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00756496 2020-12-07

LIP2SIP

Siemens Medical Solutions USA - CSG

Phase NA Completed

442 enrolled 2 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡